Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma

بواسطة Papadopoulos, Kyriakos P., Romero, Rebecca S., Gonzalez, Gabriela, Dix, James E., Lowy, Israel, Fury, Matthew
الحاوية / القاعدة Oncologist (2017)

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial

بواسطة Papadopoulos, Kyriakos P., Ben-Ami, Eytan, Patnaik, Amita, Trone, Denise, Li, Jianke, Demetri, George D.
الحاوية / القاعدة BMC Cancer (2018)

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours

بواسطة Tachibana, Masaya, Papadopoulos, Kyriakos P., Strickler, John H., Puzanov, Igor, Gajee, Roohi, Wang, Yibin, Zahir, Hamim
الحاوية / القاعدة Br J Clin Pharmacol (2017)

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

بواسطة Papadopoulos, Kyriakos P., Lakhani, Nehal, Falchook, Gerald S., Riley, Gosia, Baeck, Johan, Brown, Karen S., Gordon, Gilad, Le, Lidya, Wang, Judy S.
الحاوية / القاعدة Cancer Immunol Immunother (2020)

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

بواسطة Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony
الحاوية / القاعدة Invest New Drugs (2018)

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies

بواسطة Ou, Ying, Xu, Yang, Gore, Lia, Harvey, R. Donald, Mita, Alain, Papadopoulos, Kyriakos P., Wang, Zhengping, Cutler, Richard E., Pinchasik, Dawn E., Tsimberidou, Apostolia M.
الحاوية / القاعدة Br J Clin Pharmacol (2018)

A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors

بواسطة Papadopoulos, Kyriakos P, Tsai, Frank, Hamid, Omid, Xiao, Feng, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Karakunnel, Joyson J, Lai, Dominic W, Mahipal, Amit
الحاوية / القاعدة J Immunother Cancer (2015)

Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with...

بواسطة Naing, Aung, Eder, Joseph P, Piha-Paul, Sarina A, Gimmi, Claude, Hussey, Elizabeth, Zhang, Sen, Hildebrand, Vera, Hosagrahara, Vinayak, Habermehl, Christina, Moisan, Jacques, Papadopoulos, Kyriakos P
الحاوية / القاعدة J Immunother Cancer (2020)

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis

بواسطة Paccaly, Anne J., Migden, Michael R., Papadopoulos, Kyriakos P., Yang, Feng, Davis, John D., Rippley, Ronda K., Lowy, Israel, Fury, Matthew G., Stankevich, Elizabeth, Rischin, Danny
الحاوية / القاعدة Adv Ther (2021)

Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohor...

بواسطة Tannir, Nizar M., Papadopoulos, Kyriakos P., Wong, Deborah J., Aljumaily, Raid, Hung, Annie, Afable, Manuel, Kim, Jong Seok, Ferry, David, Drakaki, Alexandra, Bendell, Johanna, Naing, Aung
الحاوية / القاعدة Int J Cancer (2021)

Phase I Dose-Escalation Study of EZN-2208 (PEG-SN38), a Novel Conjugate of Poly(ethylene) Glycol and SN38, Administered Weekly in Patients With Advanced Cancer

بواسطة Patnaik, Amita, Papadopoulos, Kyriakos P., Tolcher, Anthony W., Beeram, Muralidhar, Urien, Saïk, Schaaf, Larry J., Tahiri, Sanaa, Bekaii-Saab, Tanios, Lokiec, François M., Rezaï, Keyvan, Buchbinder, Aby
منشور في 2013

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

بواسطة Papadopoulos, Kyriakos P., Burris, Howard A., Gordon, Michael, Lee, Peter, Sausville, Edward A., Rosen, Peter J., Patnaik, Amita, Cutler, Richard E., Wang, Zhengping, Lee, Susan, Jones, Suzanne F., Infante, Jeffery R.
منشور في 2013

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

بواسطة Patnaik, Amita, Gordon, Michael, Tsai, Frank, Papadopoulos, Kyriakos P., Rasco, Drew, Beeram, Muralidhar, Fu, Siqing, Janku, Filip, Hynes, Scott M., Gundala, Sushma R., Willard, Melinda D., Zhang, Wei, Lin, Aimee Bence, Hong, David
الحاوية / القاعدة Cancer Chemother Pharmacol (2018)

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

بواسطة Dutoit, Valérie, Taub, Robert N., Papadopoulos, Kyriakos P., Talbot, Susan, Keohan, Mary-Louise, Brehm, Michelle, Gnjatic, Sacha, Harris, Paul E., Bisikirska, Brygida, Guillaume, Philippe, Cerottini, Jean-Charles, Hesdorffer, Charles S., Old, Lloyd J., Valmori, Danila
منشور في 2002

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

بواسطة Tolcher, Anthony W., Rodrigueza, Wendi V., Rasco, Drew W., Patnaik, Amita, Papadopoulos, Kyriakos P., Amaya, Alex, Moore, Timothy D., Gaylor, Shari K., Bisgaier, Charles L., Sooch, Mina P., Woolliscroft, Michael J., Messmann, Richard A.
منشور في 2013

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer

بواسطة Lush, Richard M., Patnaik, Amita, Sullivan, Daniel, Papadopoulos, Kyriakos P., Trucksis, Michele, McCrea, Jacqueline, Cerchio, Kristine, Li, Xiaodong, Stroh, Mark, Selverian, Diana, Orford, Keith, Ebbinghaus, Scot, Agrawal, Nancy, Iwamoto, Marian, Wagner, John A., Tolcher, Anthony
منشور في 2012

A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers

بواسطة Tolcher, Anthony, Flaherty, Keith, Shapiro, Geoffrey I., Berlin, Jordan, Witzig, Thomas, Habermann, Thomas, Bullock, Andrea, Rock, Edwin, Elekes, Agnes, Lin, Chester, Kostic, Dusan, Ohi, Naoto, Rasco, Drew, Papadopoulos, Kyriakos P., Patnaik, Amita, Smith, Lon, Cote, Gregory M.
الحاوية / القاعدة Oncologist (2018)

CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study

بواسطة Naing, Aung, Infante, Jeffrey R, Papadopoulos, Kyriakos P, Autio, Karen A, Wong, Deborah J, Falchook, Gerald S, Patel, Manish R, Pant, Shubham, Whiteside, Melinda, Bendell, Johanna, Bauer, Todd M, Janku, Filip, Javle, Milind, Colen, Rivka, Tannir, Nizar, Oft, Martin
الحاوية / القاعدة J Immunother Cancer (2015)

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

بواسطة Molife, L Rhoda, Yan, Li, Vitfell-Rasmussen, Joanna, Zernhelt, Adriane M, Sullivan, Daniel M, Cassier, Philippe A, Chen, Eric, Biondo, Andrea, Tetteh, Ernestina, Siu, Lillian L, Patnaik, Amita, Papadopoulos, Kyriakos P, de Bono, Johann S, Tolcher, Anthony W, Minton, Susan
منشور في 2014

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay

بواسطة Lee, Susan J., Levitsky, Konstantin, Parlati, Francesco, Bennett, Mark K., Arastu‐Kapur, Shirin, Kellerman, Lois, Woo, Tina F., Wong, Alvin F., Papadopoulos, Kyriakos P., Niesvizky, Ruben, Badros, Ashraf Z., Vij, Ravi, Jagannath, Sundar, Siegel, David, Wang, Michael, Ahmann, Gregory J., Kirk, Christopher J.
الحاوية / القاعدة Br J Haematol (2016)